Gilead Sciences (GILD) Net Equity Issued and Repurchased (2009 - 2026)
Gilead Sciences (GILD) posted Net Equity Issued and Repurchased of -$346 million for Q2 2026, compared with -$500 million a year earlier.
Powered by 
Analysis
Gilead Sciences (GILD) Net Equity Issued and Repurchased (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Gilead Sciences was -$1.14 billion; for FY2025, it came in at -$1.51 billion.
- In prior years, Gilead Sciences' Net Equity Issued and Repurchased was -$728 million in FY2024, -$768 million in FY2023, -$1.09 billion in FY2022 and -$377 million in FY2021.
- Quarterly Net Equity Issued and Repurchased has run from a low of -$616 million in Q4 2022 to a high of -$37 million in Q4 2021 over five years.
- According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was -$253 million (Q1 2026), -$198 million (Q4 2025) and -$338 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | -103.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -283.00 Mn |
| Jun 30, 2026 | -346.00 Mn |
| Mar 31, 2026 | -253.00 Mn |
| Dec 31, 2025 | -198.00 Mn |
| Sep 30, 2025 | -338.00 Mn |
| Jun 30, 2025 | -500.00 Mn |
| Mar 31, 2025 | -478.00 Mn |
| Dec 31, 2024 | -177.00 Mn |
| Sep 30, 2024 | -202.00 Mn |
| Jun 30, 2024 | -95.00 Mn |
| Mar 31, 2024 | -254.00 Mn |
| Dec 31, 2023 | -124.00 Mn |
| Sep 30, 2023 | -217.00 Mn |
| Jun 30, 2023 | -124.00 Mn |
| Mar 31, 2023 | -303.00 Mn |
| Dec 31, 2022 | -616.00 Mn |
| Sep 30, 2022 | -144.00 Mn |
| Jun 30, 2022 | -69.00 Mn |
| Mar 31, 2022 | -258.00 Mn |
| Dec 31, 2021 | -37.00 Mn |
API Access
Gilead Sciences Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();